Molecular methods are being used in cervical cancer screening to identify high-risk human papillomavirus. Annually, 490,000 new infections are diagnosed with papillomavirus, and about 298,000 death cases due to cervical cancer worldwide. Pap and biopsy samples from 65 samples from cervixes were collected from women with histological changes from Alsider Teaching Hospital, Maysan Hospital for Children, South of Iraq. The viruses were detected by RT-PCR in 69.2 % of the all cases. Extracted RNA samples were used to analyze the gene expression of Toll-like receptor 4 and hypoxia-inducible transcription factor 1α from biopsy samples. It was found that the number of positive samples for viruse genotype 16 was in 30 samples, which represents 66.6 %, while the genotype 18 was detected in 17 samples, which represents 37.7%, while 9 samples gave positive results for genotype 31 and represented about 20 %, relying on E6 or E7 specific primers in cDNA template by real-time PCR ,and the values of Toll-like receptor 4 in negative samples were normalized to the housekeeping gene (β actin) to 1 and its values in positive samples were compared to that 1 which was more roughly in 1-fold, and the hypoxia-inducible transcription factor 1α gene expression in positive samples was more in roughly 48-fold compared to its value in the housekeeping gene (β actin) to 1 (negative control). The study concluded that toll-like receptor 4 and hypoxia-inducible transcription factor 1α are overexpressed in cervical cancer, and both synergistically promote the development of cervical cancer.